Paragraph (4)(a) of the Policy lists three elements that the Complainant must prove to merit a finding that the disputed domain name registered by the Respondent be transferred to the Complainant:
1) the disputed domain name is identical or confusingly similar to a trademark or service mark ("mark") in which the Complainant has rights; and
2) the Respondent has no rights or legitimate interests in respect of the disputed domain name; and
3) the disputed domain name has been registered and is being used in bad faith.
The Panel is satisfied the Complainant has satisfied all three elements for the principal reasons set out below.
RIGHTS IN AN IDENTICAL OR CONFUSINGLY SIMILAR TRADEMARK
The Complainant has claimed registered rights over a number of trademarks consisting of the word BIODERMA in a number of countries over many decades. This includes in its home jurisdiction of France.
To satisfy paragraph 4(a)(i) of the Policy it is enough that the Panel is satisfied that the Complainant has registered rights in a single trademark in a single jurisdiction that predates the registration of the disputed domain name (even if that single jurisdiction is not one in which the Respondent resides or operates) (Koninklijike KPN N.V. v. Telepathy, Inc D2001-0217 (WIPO 7 May 2001); see also WIPO Case Nos. D2012-0141 and D2011-1436).
Hence here registered rights in BIODERMA are established.
The next question is whether the disputed domain name is confusingly similar to this trademark.
The disputed domain name consists of the distinctive BIODERMA trademark followed by the non-distinctive gTLD <.live>. An internet user viewing the disputed domain name will simply see it as part of the Complainant's portfolio of domain names containing, or consisting of, the trademark BIODERMA.
The Panel is therefore satisfied that <BIODERMA.LIVE> is confusingly similar to a trademark in which the Complainant has rights.
NO RIGHTS OR LEGITIMATE INTERESTS
The Respondent's name bears no resemblance to the disputed domain name. Further, the disputed domain name resolves to a website purporting to offer the disputed domain name for sale. None of these factors indicate any rights or legitimate interests that the Respondent may have.
There is simply no basis to conclude that the Respondent has rights or interests in the disputed domain name.
BAD FAITH
It is undisputed that the BIODERMA is a well-known brand used on products sold by the Complainant into over 130 countries. It is also a distinctive trademark that bears no resemblance to a generic word or phrase. Further, even though the disputed domain name has only been registered for a short period of time the fact it is offered for sale in such circumstances is does not assist the Respondent in indicating a possible good faith reason for the registration. Rather, the combined facts indicate the Respondent registration was opportunistic.
These facts indicate that the Respondent knew of the said trademark before seeking to register the disputed domain name and its subsequent offering for sale of the disputed domain name at auction only further confirms its lack of bona fides. Further, there is no response from the Respondent to contradict this inference that the Panel draws under Rule 14(b) and (5)(a) of the UDRP Rules.
As the Panel has found the Respondent had such prior knowledge of the BIODERMA trademark at the time of registering the disputed domain name it can only follow that its purpose in registering the disputed domain name was to opportunistically profit from such confusing similarity through auction. The Respondent targeted the Complainant's well-known name for this purpose. Such opportunism has been recognised as bad faith by numerous panels, the Panel refers to the commentary of the learned Gerald M Levine, Domain Name Arbitration, Legal Corner Press, 2nd ed. 2019, pp. 432 to 434.
Therefore, in consideration of all the circumstances the disputed domain name has been registered and is being used in bad faith.
|